Logo

American Heart Association

  2
  0


Final ID: WMP53

Pre-hospital Arrival Times in 25 countries across regions: A Cross-Country Analysis from Registry of Stroke Care Quality (RES-Q)

Abstract Body: Background: Treatment options and outcomes in stroke also depends on pre-hospital delays. The goal of this study is to describe onset-to-door times (ODT) across many countries and also investigate how the mode of arrival affects ODT.
Methods: This is an analysis of the data from the Registry of Stroke Care Quality (RES-Q), years 2022 & 2023. RES-Q is used across the world for audit of clinical care. Data were stratified by the mode of arrival (EMS vs. non-EMS). Median ODT were analyzed, and 95% confidence intervals (CI) were calculated for each country and arrival mode.
Results: Of 334,184 patients from 1,130 hospitals in 70 countries, 155,532 patients from 25 countries were diagnosed with acute ischemic stroke after excluding secondary transfers (n=32,349), cases from countries with fewer than 1,000 cases (n=128,660), and those with missing data or typing errors (n=17,643). The median ODT was 193 mins (95% CI: 164-223) for patients arriving by EMS and 309 mins (95% CI: 274-360) for those arriving by non-EMS. The percentage of EMS arrival by region was 34% (Africa), 30% (Asia), 39% (Latin America), and 87% (Europe). The percentage of EMS arrivals is shown in Figure 1. Compared to the patients who reached by non-EMS mode, patients who reached by EMS mode were more likely to receive intravenous thrombolysis (16% vs 44%,). The ODTs by mode of arrival and country are detailed in Figure 2.
Conclusions: Transport via EMS was associated with a reduced arrival time nearly by 2 hours and tripled the chance of receiving thrombolysis as compared to non-EMS transportation. The percentage of patients arriving by EMS was higher in European countries as compared to Africa, Asia and Latin America and this is reflected by shorter ODT in many EU countries. Improvements in EMS infrastructure could improve stroke outcomes globally.
  • Mikulik, Robert  ( St Annes University Hospital , Brno , Czechia )
  • Sohn, Sung-il  ( Keimyung Univ. Dongsan Hospital , Daegu , Korea (the Republic of) )
  • Suwanwela, Nijasri  ( Chulalongkorn University , Bangkok , Thailand )
  • Sylaja, Pn  ( SCTIMST , Trivandrum , India )
  • Nguyen, Huy Thang  ( People's Hospital 115 , Ho Chi Minh , Viet Nam )
  • Tsivgoulis, Georgios  ( Neurodiagnostics PC , Athens , Greece )
  • Van Der Worp, H  ( UMC UTRECHT , Utrecht , Netherlands )
  • Neto, Geraldo  ( St Annes University Hospital , Brno , Czechia )
  • Sedani, Rupal  ( RESQ Global , Brno , Czechia )
  • Asif, Kaiz  ( Ascension Health and UIC - Chicago , Chicago , Illinois , United States )
  • Bornstein, Natan  ( SHAARE-ZEDEK MEDICAL CENTER , Jerusalem , Israel )
  • Hill, Michael  ( UNIVERSITY CALGARY , Calgary , Alberta , Canada )
  • Lavados, Pablo  ( CLINICA ALEMANA DE SANTIAGO , Santiago , Chile )
  • Martins, Sheila  ( Federal University of Rio Grande do Sul , Porto Alegre , Brazil )
  • Middleton, Sandy  ( Nursing Research Institute , Darlihurst , New South Wales , Australia )
  • Author Disclosures:
    Robert Mikulik: DO NOT have relevant financial relationships | Sung-il Sohn: DO NOT have relevant financial relationships | Nijasri Suwanwela: DO NOT have relevant financial relationships | PN Sylaja: DO NOT have relevant financial relationships | Huy Thang Nguyen: DO NOT have relevant financial relationships | Georgios Tsivgoulis: DO NOT have relevant financial relationships | H Van Der Worp: DO have relevant financial relationships ; Consultant:TargED:Active (exists now) ; Individual Stocks/Stock Options:Philips:Active (exists now) ; Research Funding (PI or named investigator):Bayer:Active (exists now) ; Consultant:Boehringer Ingelheim:Past (completed) | Geraldo Neto: DO NOT have relevant financial relationships | Rupal Sedani: DO NOT have relevant financial relationships | Kaiz Asif: DO have relevant financial relationships ; Individual Stocks/Stock Options:Solaris X Labs:Active (exists now) ; Individual Stocks/Stock Options:Galaxy Therapeutics:Active (exists now) ; Individual Stocks/Stock Options:Gravity Medical Technology:Active (exists now) | Natan Bornstein: DO NOT have relevant financial relationships | Michael Hill: DO have relevant financial relationships ; Consultant:Brainsgate Inc:Past (completed) ; Individual Stocks/Stock Options:Circle Inc:Active (exists now) ; Individual Stocks/Stock Options:Basking Bioscience:Active (exists now) ; Research Funding (PI or named investigator):Boehringer-Ingelheim:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Consultant:Diamedica Inc:Active (exists now) | Pablo Lavados: No Answer | Sheila Martins: DO have relevant financial relationships ; Speaker:Boehringer Ingelheim:Active (exists now) ; Research Funding (PI or named investigator):Ministry of Health of Brazil:Active (exists now) ; Speaker:Daiichi Sankyo:Past (completed) ; Speaker:Pfizer:Past (completed) ; Speaker:Bayer:Past (completed) ; Speaker:Servier:Past (completed) ; Speaker:Novo Nordisk:Past (completed) ; Speaker:Novartis:Past (completed) ; Speaker:Penumbra:Past (completed) ; Speaker:Astra Zeneca:Active (exists now) ; Speaker:Medtronic:Active (exists now) | Sandy Middleton: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Health Services, Quality Improvement, and Patient-Centered Outcomes Moderated Poster Tour I

Wednesday, 02/05/2025 , 06:00PM - 07:00PM

Moderated Poster Abstract Session

More abstracts on this topic:
3-HKA Promotes the Vascular Remodeling after Stroke by Modulating the Activation of A1/A2 Reactive Astrocytes

Chen Jun-min, Shi Guang, Yu Lulu, Shan Wei, Zhang Xiangjian, Wang Qun

An Intensive Lifestyle Intervention Improves Cardiovascular Health Outcomes in Patients with Type-2 Diabetes

Tripathi Pramod, Kathrikolly Thejas, Sul Lidiya, Lee Matthew, Nanjundappa Aravinda, Kapadia Samir, Kadam Nidhi

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)